Preliminary laboratory studies indicate that two doses of the Pfizer / BioNTech vaccine may not provide sufficient protection against the omicron variant of the coronavirus, but three doses are capable of neutralizing it.
The pharmaceutical firms, in a statement released today, indicated that a group of patients who had received two doses of the vaccine against covid-19 showed an efficacy against the omicron variant 25 times less than against the virus in its previous variant.
–
Related posts:
Recognize the Dangers and How to Detect Cataracts Early
Pay Attention, This Is The Impact When Adolescents Experience Chronic Malnutrition
Corona caused the number of organ donors to drop by 20 percent in 2020 - Belgium
Consumers increasingly sensitive to health preservation: Organic products, a growing global trend
